The stock of Baxter International Inc (BAX) has seen a -0.91% decrease in the past week, with a -17.95% drop in the past month, and a -6.95% decrease in the past quarter. The volatility ratio for the week is 8.42%, and the volatility levels for the past 30 days are at 4.37% for BAX. The simple moving average for the last 20 days is -10.80% for BAX stock, with a simple moving average of -16.95% for the last 200 days.
Is It Worth Investing in Baxter International Inc (NYSE: BAX) Right Now?
The stock has a 36-month beta value of 0.68. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 3 as “overweight,” 11 as “hold,” and 1 as “sell.”
The public float for BAX is 508.69M, and at present, short sellers hold a 3.57% of that float. On April 15, 2025, the average trading volume of BAX was 5.06M shares.
BAX) stock’s latest price update
The stock price of Baxter International Inc (NYSE: BAX) has surged by 1.94 when compared to previous closing price of 27.84, but the company has seen a -0.91% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-04-10 that VIENNA–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Goldman repeating the rating for BAX by listing it as a “Buy.” The predicted price for BAX in the upcoming period, according to Goldman is $42 based on the research report published on February 26, 2025 of the current year 2025.
Barclays gave a rating of “Overweight” to BAX, setting the target price at $39 in the report published on February 20th of the current year.
BAX Trading at -13.38% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.27% of loss for the given period.
Volatility was left at 4.37%, however, over the last 30 days, the volatility rate increased by 8.42%, as shares sank -18.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.84% lower at present.
During the last 5 trading sessions, BAX fell by -0.91%, which changed the moving average for the period of 200-days by -16.28% in comparison to the 20-day moving average, which settled at $31.82. In addition, Baxter International Inc saw -2.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BAX starting from Stevens Brian, who proposed sale 976 shares at the price of $40.01 back on Sep 16 ’24. After this action, Stevens Brian now owns shares of Baxter International Inc, valued at $39,046 using the latest closing price.
Stevens Brian, the Officer of Baxter International Inc, proposed sale 16,063 shares at $39.81 during a trade that took place back on Sep 13 ’24, which means that Stevens Brian is holding shares at $639,465 based on the most recent closing price.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.37 for the gross margin
The net margin for Baxter International Inc stands at -0.05. The total capital return value is set at -0.01. Equity return is now at value -9.24, with -2.63 for asset returns.
Based on Baxter International Inc (BAX), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 1.93. The interest coverage ratio of the stock is -0.36.
Currently, EBITDA for the company is -112.0 million with net debt to EBITDA at 12.27. When we switch over and look at the enterprise to sales, we see a ratio of 2.04. The receivables turnover for the company is 7.43for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
To sum up, Baxter International Inc (BAX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
